Monsanto Company (NYSE:MON) Position Lowered by OLD National Bancorp IN
OLD National Bancorp IN reduced its position in shares of Monsanto Company (NYSE:MON) by 28.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,883 shares of the basic materials company’s stock after selling 1,581 shares during the period. OLD National Bancorp IN’s holdings in Monsanto were worth $460,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Middleton & Co Inc MA raised its stake in shares of Monsanto by 2.3% in the first quarter. Middleton & Co Inc MA now owns 14,630 shares of the basic materials company’s stock worth $1,656,000 after buying an additional 335 shares during the last quarter. Whitnell & Co. raised its stake in shares of Monsanto by 35.4% in the first quarter. Whitnell & Co. now owns 979 shares of the basic materials company’s stock worth $111,000 after buying an additional 256 shares during the last quarter. Quantitative Systematic Strategies LLC raised its stake in shares of Monsanto by 41.0% in the first quarter. Quantitative Systematic Strategies LLC now owns 22,600 shares of the basic materials company’s stock worth $2,559,000 after buying an additional 6,577 shares during the last quarter. Bank of The West raised its stake in shares of Monsanto by 55.8% in the first quarter. Bank of The West now owns 38,258 shares of the basic materials company’s stock worth $4,330,000 after buying an additional 13,703 shares during the last quarter. Finally, DnB Asset Management AS raised its stake in shares of Monsanto by 4.6% in the first quarter. DnB Asset Management AS now owns 99,357 shares of the basic materials company’s stock worth $11,247,000 after buying an additional 4,400 shares during the last quarter. 75.31% of the stock is currently owned by institutional investors.
Shares of Monsanto Company (NYSE MON) traded down 0.33% during mid-day trading on Friday, reaching $116.55. 1,012,471 shares of the company’s stock traded hands. Monsanto Company has a 12-month low of $97.35 and a 12-month high of $118.97. The firm has a market capitalization of $51.20 billion, a price-to-earnings ratio of 25.17 and a beta of 1.07. The stock has a 50-day moving average price of $117.47 and a 200 day moving average price of $115.08.
Monsanto (NYSE:MON) last issued its quarterly earnings results on Wednesday, June 28th. The basic materials company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.74 by $0.19. The company had revenue of $4.23 billion for the quarter, compared to the consensus estimate of $4.18 billion. Monsanto had a net margin of 14.11% and a return on equity of 45.26%. The firm’s revenue was up 1.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.17 EPS. Analysts anticipate that Monsanto Company will post $4.89 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, October 6th will be issued a dividend of $0.54 per share. The ex-dividend date of this dividend is Thursday, October 5th. This represents a $2.16 annualized dividend and a yield of 1.85%. Monsanto’s payout ratio is 46.75%.
MON has been the subject of a number of research analyst reports. Zacks Investment Research raised Monsanto from a “hold” rating to a “buy” rating and set a $132.00 target price for the company in a research report on Friday, June 16th. Vetr raised Monsanto from a “hold” rating to a “buy” rating and set a $122.35 price objective for the company in a report on Thursday, July 6th. BidaskClub lowered Monsanto from a “hold” rating to a “sell” rating in a report on Sunday, July 16th. Royal Bank Of Canada reissued a “sector perform” rating and set a $128.00 price objective (up from $120.00) on shares of Monsanto in a report on Thursday, June 29th. Finally, UBS AG lowered Monsanto from a “positive” rating to a “neutral” rating in a report on Tuesday, June 27th. Two equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and eight have given a buy rating to the company. Monsanto has an average rating of “Hold” and a consensus target price of $123.15.
In other Monsanto news, EVP Steven Mizell sold 11,300 shares of the company’s stock in a transaction dated Monday, July 3rd. The shares were sold at an average price of $118.57, for a total value of $1,339,841.00. Following the transaction, the executive vice president now directly owns 55,011 shares in the company, valued at approximately $6,522,654.27. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Robert T. Fraley sold 52,410 shares of the company’s stock in a transaction dated Monday, July 10th. The stock was sold at an average price of $117.95, for a total transaction of $6,181,759.50. The disclosure for this sale can be found here. Insiders sold a total of 74,470 shares of company stock worth $8,791,281 over the last 90 days. Insiders own 0.79% of the company’s stock.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.